Clinical characteristics and outcomes in Epstein-Barr virus positive diffuse large B-cell lymphoma: A retrospective multicenter study
EBV+ DLBCL is characterized by distinct clinical features, including advanced-stage disease and poorer PFS. Variability in reported prevalence highlights the need for standardized diagnostic criteria. Further research is essential to develop tailored therapeutic strategies and improve outcomes for this rare lymphoma subtype.
Authors
- Asena Dikyar (ORCID: https://orcid.org/0000-0002-9108-876X)
- Uğur Bilge
- Ahmet Kürşad Güneş (ORCID: https://orcid.org/0000-0001-5522-8342)
- Ebru Kılıç Güneş (ORCID: https://orcid.org/0000-0001-8663-3172)
- Meltem Aylı (ORCID: https://orcid.org/0000-0001-5766-5642)
- Hacer Berna Afacan Öztürk (ORCID: https://orcid.org/0000-0001-9386-7604)
- Esra Kiriktir (ORCID: https://orcid.org/0009-0000-5994-2586)
Institutions
- Ankara University (TR)
- University of Health Science (KH)
- Sağlık Bilimleri Üniversitesi (TR)
- University of Health Sciences Antigua (AG)
Publication Details
- Journal
- TURKISH JOURNAL OF MEDICAL SCIENCES
- Published
- 2025-10-14
- DOI
- https://doi.org/10.55730/1300-0144.6066
- Primary Topic
- Lymphoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00